PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study

Although immune checkpoints inhibitors have exhibited promising activity in clinical trials in non-small cell lung cancer (NSCLC) patients, the current programmed cell death-ligand 1 (PD-L1) assays are inconsistent in terms of the staining analysis and scoring system used. To verify the interchangea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyojin, Kwon, Hyun Jung, Park, Soo Young, Park, Eunhyang, Chung, Jin-Haeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716747/
https://www.ncbi.nlm.nih.gov/pubmed/29228707
http://dx.doi.org/10.18632/oncotarget.21567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716747/
https://www.ncbi.nlm.nih.gov/pubmed/29228707
http://dx.doi.org/10.18632/oncotarget.21567

Ejemplares similares